Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral therapy

被引：2
作者：
Kawsar, M [1 ]
机构：
[1] Luton & Dunstable NHS Trust, Dept Genitourinary Med, Luton LU2 7BJ, Beds, England
来源：
INTERNATIONAL JOURNAL OF STD & AIDS | 2005年 / 16卷 / 08期
关键词：
D O I：
10.1258/0956462054679278
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：582 / 583
页数：2
相关论文
共 50 条
  • [41] The Immune Pathogenesis of Immune Reconstitution Inflammatory Syndrome Associated with Highly Active Antiretroviral Therapy in AIDS
    Zheng, Yuhuang
    Zhou, Huaying
    He, Yan
    Chen, Zi
    He, Bo
    He, Mei
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (12) : 1197 - 1202
  • [42] A Fatal Case Of Pulmonary Kaposi's Sarcoma - Associated Immune Reconstitution Syndrome After Initiation Of Art
    Abidali, M.
    Abidali, A.
    Bozak, A.
    Orr, R. Garcia
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [43] Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
    El Amari, Emmanuelle Boffi
    Toutous-Trellu, Laurence
    Gayet-Ageron, Angele
    Baumann, Michele
    Cathomas, Gieri
    Steffan, Ingrid
    Erb, Peter
    Mueller, Nicolas J.
    Furrer, Hansjakob
    Cavassini, Matthias
    Vernazza, Pietro
    Hirsch, Hans H.
    Bernasconi, Enos
    Hirschel, Bernard
    [J]. AIDS, 2008, 22 (09) : 1019 - 1028
  • [44] Kaposi's sarcoma-associated herpesvirus
    Boshoff, C
    Weiss, RA
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1997, 10 (01) : 26 - 31
  • [45] Kaposi's sarcoma-associated herpesvirus
    Boshoff, C
    Weiss, RA
    [J]. ADVANCES IN CANCER RESEARCH, VOL 75, 1998, 75 : 57 - 86
  • [46] Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma
    Martín-Carbonero, L
    Barrios, A
    Saballs, P
    Sirera, G
    Santos, J
    Palacios, R
    Valencia, ME
    Alegre, M
    Podzamczer, D
    González-Lahoz, J
    [J]. AIDS, 2004, 18 (12) : 1737 - 1740
  • [47] Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis
    Liang, Chengyu
    Lee, Jong-Soo
    Jung, Jae U.
    [J]. SEMINARS IN CANCER BIOLOGY, 2008, 18 (06) : 423 - 436
  • [48] Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil
    Ramos-da-Silva, S.
    Eigui-de-Oliveira, D.
    Borges, L.
    Bacchi, C. E.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (05) : 573 - 580
  • [49] Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection
    Loke, W. C.
    Spittle, M. F.
    Mitchell, S.
    Kulasegaram, R.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (08) : 565 - 566
  • [50] Profile of patients with Kaposi's sarcoma (KS) in the era of highly active antiretroviral therapy (HAART).
    Gallafent, JH
    Buskin, S
    De Turk, P
    Aboulafia, DM
    [J]. BLOOD, 2003, 102 (11) : 280A - 280A
12345